WuXi AppTec Co., Ltd.
603259
株式のランク
#458
WuXi AppTec Co., Ltd., an investment holding company, provides research and... WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
株価
$21.16
時価総額
$52.34B
変化（1日）
-4.10%
変化（1年）
49.45%
国
CN
取引 WuXi AppTec Co., Ltd. (603259)
カテゴリー
Healthcare
WuXi AppTec Co., Ltd.（603259）の営業利益率
October 2026 時点の営業利益率 TTM: 42.43%
WuXi AppTec Co., Ltd. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 42.43% です。2024 年末時点では 35.39% でした。
WuXi AppTec Co., Ltd. の営業利益率の履歴（2014 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 42.43% | 13.42% |
| 2025 | 37.41% | 5.71% |
| 2024 | 35.39% | 15.28% |
| 2023 | 30.70% | 13.41% |
| 2022 | 27.07% | 2.69% |
| 2021 | 26.36% | 28.59% |
| 2020 | 20.50% | 12.70% |
| 2019 | 18.19% | -32.35% |
| 2018 | 26.89% | 42.96% |
| 2017 | 18.81% | -10.43% |
| 2016 | 21.00% | 32.91% |
| 2015 | 15.80% | -24.11% |
| 2014 | 20.82% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.97% | -99.58% |
US
|
|
| 20.42% | -99.52% |
US
|
|
| -10.70% | -100.25% |
US
|
|
| 22.23% | -99.48% |
US
|
|
| 13.57% | -99.68% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。